Robert Mannel to Folic Acid Antagonists
This is a "connection" page, showing publications Robert Mannel has written about Folic Acid Antagonists.
Connection Strength
0.221
-
A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study. Am J Clin Oncol. 1997 Feb; 20(1):78-80.
Score: 0.140
-
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group. J Clin Oncol. 2009 Jun 01; 27(16):2686-91.
Score: 0.081